New insights in series of ligands used as SARS-CoV-2 virus inhibitors within molecular docking, molecular quantum similarity, and chemical reactivity indices frameworks
<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a research archivist expert in dataset metadata. Answer the question truthfully.  <|eot_id|><|start_header_id|>user<|end_header_id|> Here is the Description of a dataset. Description:'Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Most people with COVID-19 experience mild to moderate symptoms and recover without the need for special treatments. The SARS‑CoV‑2 RNA‑dependent RNA polymerase (RdRp) plays a crucial role in the viral life cycle, and as the active site of the RdRp is the most conserved and accessible region, targeting this region for inhibition of viral replication may be an effective therapeutic approach. Scientists worldwide have proposed the use of preexisting drugs against the novel coronavirus. However, the efficacy of these drugs is somewhat limited. Others reported repurposing the use of existing antiviral agents in order to reduce time and cost compared to de novo drug discovery. For this reason, in this study has been selected a series of ligands used as SA' . Please return only a json list of at most 3 Keywords corresponding to the Description:.<|eot_id|><|start_header_id|>assistant<|end_header_id|> {"Answer" : ["SARS-CoV-2 virus, COVID-19 treatments, molecular docking, molecular quantum similarity, chemical reactivity indices, Density Funtional Theory."]} <|eot_id|>
 Here is the Description of a dataset. Description:'Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Most people with COVID-19 experience mild to moderate symptoms and recover without the need for special treatments. The SARS‑CoV‑2 RNA‑dependent RNA polymerase (RdRp) plays a crucial role in the viral life cycle, and as the active site of the RdRp is the most conserved and accessible region, targeting this region for inhibition of viral replication may be an effective therapeutic approach. Scientists worldwide have proposed the use of preexisting drugs against the novel coronavirus. However, the efficacy of these drugs is somewhat limited. Others reported repurposing the use of existing antiviral agents in order to reduce time and cost compared to de novo drug discovery. For this reason, in this study has been selected a series of ligands used as SA' . Please return only a json list of at most 3 Keywords corresponding to the Description:.
Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Most people with COVID-19 experience mild to moderate symptoms and recover without the need for special treatments. The SARS‑CoV‑2 RNA‑dependent RNA polymerase (RdRp) plays a crucial role in the viral life cycle, and as the active site of the RdRp is the most conserved and accessible region, targeting this region for inhibition of viral replication may be an effective therapeutic approach. Scientists worldwide have proposed the use of preexisting drugs against the novel coronavirus. However, the efficacy of these drugs is somewhat limited. Others reported repurposing the use of existing antiviral agents in order to reduce time and cost compared to de novo drug discovery. For this reason, in this study has been selected a series of ligands used as SA
SARS-CoV-2 virus, COVID-19 treatments, molecular docking, molecular quantum similarity, chemical reactivity indices, Density Funtional Theory.